Company Filing History:
Years Active: 2022-2025
Title: Innovations by Nu Zhang in PTEN Gene Research
Introduction
Nu Zhang is a prominent inventor based in Guangdong, China. She has made significant contributions to the field of genetic research, particularly focusing on the Phosphatase and Tensin homolog (PTEN) gene. With a total of 3 patents, her work has the potential to impact the diagnosis and treatment of various tumors.
Latest Patents
Nu Zhang's latest patents include groundbreaking research on the use of upstream open reading frames (uORFs) of the PTEN gene. One of her notable patents describes a 45 amino acid oligopeptide, named PTEN-45aa, which plays a crucial role in tumor development and progression. This patent also outlines a new diagnostic and therapeutic method, along with a drug screening platform for diseases related to PTEN expression regulation, particularly neuroglioma. Another patent focuses on a 31 amino acid oligopeptide, PTEN-31aa, which is similarly significant in tumor progression and offers new avenues for diagnosis and treatment of gliomas.
Career Highlights
Nu Zhang is affiliated with The First Affiliated Hospital, Sun Yat-sen University, where she conducts her research. Her work has garnered attention for its innovative approach to understanding the PTEN gene and its implications in cancer treatment.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Nu Zhang's contributions to the field of genetic research, particularly regarding the PTEN gene, highlight her role as an influential inventor. Her patents pave the way for new diagnostic and therapeutic methods that could significantly improve treatment options for patients with related diseases.